Physicians are cautioned that the two obstacles to reforming post-marketing clinical trials are the FDA's reluctance to revisit past approvals and its inability to enforce pharmaceutical companies' commitment to conduct Phase IV trials.
Physicians who are faced with a patient who refuses to undergo prescribed annual screening should attempt to engage them in shared decision making and educate the patient about the risks and benefits of the test.
Physicians who are faced with a patient who refuses to undergo prescribed annual screening should attempt to engage them in shared decision making and educate the patient about the risks and benefits of the test.
Health care professionals have a responsibility to educate patients about public screening programs and ensure that subsequent follow-up is done after the screening is completed.
Cross-cultural ethics should be regarded by physicians as an area of medical expertise that can help resolve conflicts that arise between the health traditions of international patients and those traditions that are upheld in the United States.